This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Reasons Why Applied Industrial (AIT) is Worth Buying Now
by Zacks Equity Research
Applied Industrial (AIT) is poised to gain on added growth opportunities from acquired assets and solid product offerings. Its cost-saving initiatives and policy of rewarding shareholders bode well.
Cintas (CTAS) Tops on Q3 Earnings, Gives Solid Sales View
by Zacks Equity Research
Cintas' (CTAS) Q3 results reflect the impacts of lower revenues as well as a decline in costs and expenses. The company anticipates Q4 revenues to improve sequentially.
Colfax (CFX) Commences Public Offering of 14M Common Shares
by Zacks Equity Research
Colfax (CFX) offers 14 million common shares to the public in an underwritten offer. The funds raised will be used for funding general corporate purposes and working capital needs.
Zacks.com featured highlights include: Veritiv Corp, Danaos Corp, Select Medical Holdings, EnPro Industries and ArcelorMittal
by Zacks Equity Research
Zacks.com featured highlights include: Veritiv Corp, Danaos Corp, Select Medical Holdings, EnPro Industries and ArcelorMittal
5 Stocks With Recent Price Strength to Enhance Your Returns
by Nalak Das
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength like VRTV, DAC, SEM, NPO and MT have a high chance of carrying the momentum forward.
Top Ranked Momentum Stocks to Buy for March 12th
by Zacks Equity Research
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 12th
IDEX (IEX) Completes Abel Pumps Buyout, Expands Presence
by Zacks Equity Research
IDEX's (IEX) Abel Pumps acquisition will enable it to strengthen its position in the pump manufacturing industry.
IDEX (IEX) to Gain From Products & Buyouts, Headwinds Persist
by Zacks Equity Research
IDEX (IEX) stands to gain from improving end markets, growth investments, solid product portfolio and acquired assets. However, weakness in energy end market might weigh on its performance.
Roper (ROP) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its businesses, acquired assets and shareholder-friendly policies. However, the high debt level poses a concern.
Colfax (CFX) Plans to Split Businesses Into Separate Companies
by Zacks Equity Research
Colfax's (CFX) plan of dividing its fabrication technology and medical technology businesses into two separate companies will likely unlock significant values for each of its businesses.
Middleby (MIDD) to Benefit From Products & Acquisitions
by Zacks Equity Research
Middleby (MIDD) is likely to benefit from product innovation and technological-advancement actions, along with acquired assets. Its strong liquidity position also bodes well.
Here's Why You Should Consider Investing in Graco (GGG) Now
by Zacks Equity Research
Graco (GGG) is poised to benefit from solid portfolio of products, investments in product innovation and capacity expansion, and shareholder-friendly policies.
The Zacks Analyst Blog Highlights: ACM Research, Deere & Co, EnPro Industries, iRobot and Crown Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ACM Research, Deere & Co, EnPro Industries, iRobot and Crown Holdings
Middleby (MIDD) in Focus: Stock Moves 8.8% Higher
by Zacks Equity Research
Middleby (MIDD) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.
5 Stocks to Buy Amid Continued Expansion in Manufacturing
by Kaustav Ghosh
The U.S. manufacturing sector continues to expand after the COVID-induced slump early last year, making it wise to look at names like ACM Research (ACMR), EnPro Industries (NPO) and iRobot (IRBT).
Parker-Hannifin (PH) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Parker-Hannifin (PH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
NPO vs. SOTK: Which Stock Is the Better Value Option?
by Zacks Equity Research
NPO vs. SOTK: Which Stock Is the Better Value Option?
Tetra Tech (TTEK) Wins $38.8M Single-Award Deal From USAID
by Zacks Equity Research
Tetra Tech's (TTEK) deal with USAID will help it expand the distribution of adequate sustainable energy in Indonesia.
Colfax (CFX) Q4 Earnings Top Estimates, 2021 View Impressive
by Zacks Equity Research
Colfax's (CFX) Q4 earnings decrease year over year, reflecting the impacts of weak sales generation and a decline in margins. For 2021, it anticipates y/y revenue and earnings growth.
The Zacks Analyst Blog Highlights: Schnitzer Steel Industries, Applied Industrial Technologies, International Paper, EnPro Industries and Hain Celestial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Schnitzer Steel Industries, Applied Industrial Technologies, International Paper, EnPro Industries and Hain Celestial
Illinois Tool (ITW) Beats on Q4 Earnings, Gives Solid View
by Zacks Equity Research
Illinois Tool's (ITW) Q4 earnings improve year over year on revenue generation and margin improvement. Earnings and revenue projections for 2021 reflect y/y growth.
5 Stocks Set to Gain on Continued Rise in Factory Orders
by Zacks Equity Research
The U.S. economy seems poised to witness a turnaround as factory orders signal continued recovery, making it a good time to invest in names like International Paper (IP) and EnPro Industries (NPO).
IDEX (IEX) Q4 Earnings Beat Estimates, 2021 View Impressive
by Zacks Equity Research
IDEX's (IEX) Q4 earnings top estimates as well as rise from the year-ago level on sales growth and a higher operating margin. The company also predicts a year-over-year progress in 2021 organic sales.
Xylem (XYL) Beats Q4 Earnings Estimates, Gives Impressive View
by Zacks Equity Research
Xylem's (XYL) Q4 earnings decline year over year due to weakness in organic sales and margins. For 2021, earnings and sales are anticipated to increase year over year.
Kennametal (KMT) Tops on Q2 Earnings, Expects Q3 Sales Growth
by Zacks Equity Research
Kennametal's (KMT) Q2 earnings beat estimates but decrease y/y due to weak sales generation. It expects mid- to high-single-digit sequential growth in sales for Q3.